Medical Translation: Quality Standards and Criteria for Choosing the Right Provider

A poorly translated medicine leaflet, an ambiguous clinical trial protocol, an inaccurate patient file: in medical translation, one error can have serious consequences for human health. Here is what distinguishes this field from all other translation — and how to identify the right service provider.

What does medical translation cover?

Professional medical translation is a vast field encompassing very different types of documents, each with its own specific constraints:

• Patient files: hospitalisation reports, test results, radiology reports, referral letters between practitioners
• Clinical trials: study protocols, informed consent forms, adverse event reports, CTD (Common Technical Document) modules
• Medicine packaging and leaflets: Summaries of Product Characteristics (SmPC), patient leaflets, labelling
• Medical devices: instructions for use, technical manuals, CE conformity dossiers
• Scientific and medical publications: research articles, systematic reviews, conference communications
• Regulatory documents: EMA (European Medicines Agency) and FDA submissions, marketing authorisation (MA) dossiers
• Medical training: e-learning for healthcare professionals, training materials for devices or procedures

Why medical translation is radically different

Three factors fundamentally distinguish medical translation from any other professional translation:

1. Terminological precision is vital — literally

In medical translation, there are no acceptable synonyms. "Antihypertensive" cannot be replaced by "blood pressure medication" in a clinical document. "Lethal dose" cannot be approximated. Anatomical terms have internationally codified precise nomenclatures (Terminologia Anatomica).

Confusion between "myocardial infarction" and "heart failure" in a patient file transmitted to a foreign physician can lead to inappropriate treatment. A dosage error in a translated medicine leaflet can cause overdose. These situations are not theoretical — they have documented precedents.

2. Strict regulations to comply with

Medical translations do not take place in a regulatory vacuum. In Europe, EU Regulation 2017/745 on medical devices imposes precise requirements on the translation of instructions for use. Regulation 536/2014 governs clinical trials and imposes standards for consent forms. The EMA defines strict formats for regulatory submissions.

In the United States, the FDA requires that translations of submitted documents be certified as accurate. Non-compliance with these requirements can lead to rejected dossiers, regulatory fines, and even market withdrawals.

3. The medical translator's profile is very specific

A competent medical translator necessarily combines two areas of training: translation training (mastery of translation techniques, professional tools, bilingual terminology) AND training or experience in the medical or pharmaceutical field.

This profile is rare and therefore costly. A generalist translator, however linguistically brilliant, cannot correctly translate a Phase III clinical trial protocol without training in clinical pharmacology. Conversely, a bilingual physician without translation training risks producing a text that is stylistically inappropriate for the required format.

The concrete risks of poor medical translation

The consequences of insufficient medical translation go far beyond mere linguistic discomfort:

• Patient risk: misunderstanding a medicine leaflet, confusion about contraindications, poorly understood medical device instructions
• Regulatory risk: rejection of an EMA or FDA submission, need to retranslate entire CTD modules, market launch delays potentially costing millions
• Legal risk: product liability litigation if a defective translation is involved in an incident
• Clinical trial risk: a poorly translated consent form can invalidate the inclusion of patients or even call study results into question
• Reputational risk: for laboratories and manufacturers, insufficient translation of professional documents erodes the confidence of healthcare professionals and regulators

How to choose the right medical translation provider

Some concrete criteria for evaluating a provider before entrusting them with your medical documents:

• Request translators' CVs: what medical or pharmaceutical training? Which working languages? What types of documents have they previously translated?
• Verify the revision process: is there a review by a second medical translator? (ISO 17100 requirement)
• Ask about terminology management: does the provider use validated medical terminology databases (MeSH, SNOMED, INN for International Non-proprietary Names)?
• Check GDPR compliance: patient files contain health data — a special category under GDPR. Does the provider offer a DPA? Where are files stored?
• Request sector references: have they previously worked for pharmaceutical companies, medical device manufacturers, or CROs (Contract Research Organisations)?

TranslateBE and medical translation

At TranslateBE, all our medical translators have dual competence: translation training AND a background in the medical, paramedical, or pharmaceutical field. We work for hospitals, laboratories, medical device manufacturers, clinical research organisations, and healthcare professionals based in Belgium, France, Luxembourg, and Switzerland.

Our process systematically includes review by a second medical translator and terminological verification against sector reference databases. All our translators have signed an NDA. Our files are stored on EU servers and deleted 30 days after delivery.